EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity Against Mycobacterium abscessus: Integrated In Silico and In Vitro Evidence

Roseane Lustosa de Santana Lira, Fabiane Barbosa Mendes iD, Pedro Lucas Brito Tromps Roxo iD, Joana Tenório Albuquerque Madruga Mesquita Meireles Teixeira, Caio César Santana de Azevedo, Arícia de Azevedo Vidigal, Eleonôra Costa Monteiro Gimenes, Reidson Stanley Soares Dos Santos, Rivaldo Lira Filho, Camila Evangelista Carnib Nascimento, Flávia Danyelle Oliveira Nunes iD, Mayane Cristina Pereira Marques und 5 weitere

International Journal of Molecular Sciences · 26.06.2026 · 27 (13) · 5789

DOI: 10.3390/ijms27135789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.06.2026. Verfasst von Roseane Lustosa de Santana Lira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Health Sciences, Federal University of Maranhão-UFMA, São Luís 65080-805, Brazil. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Deferoxamine, Anti-Bacterial Agents, Immunomodulating Agents. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Universidade Ceuma, Foundation for the Support of Research and Scientific and Technological Development of Maranhão.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus subsp. massiliense (Mabs) is an emerging nontuberculous mycobacterium associated with difficult-to-treat infections due to intrinsic antimicrobial resistance, intracellular persistence, biofilm formation, and limited responsiveness to currently available therapeutic regimens. In this context, adjuvant strategies targeting iron-dependent metabolic pathways and metal homeostasis may enhance the efficacy of conventional antimicrobials. This study investigated deferoxamine (DFO), a clinically approved iron chelator, as a potential adjuvant against Mabs using integrated in vitro and in silico approaches. Cytocompatibility was assessed using an MTT assay in RAW 264.7 macrophages and a hemolysis assay in human erythrocytes. Antimicrobial activity was evaluated through minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays, while interactions with clarithromycin (CLA) and amikacin (AMK) were assessed using the checkerboard method. Effects on virulence-associated phenotypes were examined through biofilm formation assays and protein quantification in extracellular vesicle-enriched fractions. Intracellular activity and modulation of inflammatory mediator gene expression were investigated in Mabs-infected RAW 264.7 macrophages through colony-forming unit (CFU) recovery and reverse transcription quantitative polymerase chain reaction (qPCR). DFO exhibited low cytotoxicity and negligible hemolytic activity under the tested conditions. Direct antimicrobial testing revealed a predominantly bacteriostatic profile (MIC = 9.75 µg/mL; MBC > 10 mg/mL), whereas checkerboard analysis suggested a synergistic interaction with CLA (FICI = 0.047), which requires further confirmation by time-kill or CFU-based combination assays. Furthermore, DFO reduced biofilm biomass, decreased protein levels in vesicle-enriched fractions, lowered intracellular bacterial burden, and modulated cytokine gene expression in infected macrophages. Molecular docking, ADME/Tox, and PASS analyses generated exploratory hypotheses regarding potential molecular interactions and pharmacological properties. Overall, these findings support DFO as a promising experimental adjuvant candidate for further investigation against Mabs, particularly in combination with clarithromycin. However, confirmation of a putative iron-restriction-associated mechanism and its translational relevance will require validation in additional clinical isolates, iron-rescue experiments, mature biofilm models, and in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusDeferoxamineAnti-Bacterial AgentsImmunomodulating AgentsMiceAnimalsHumansRAW 264.7 CellsMicrobial Sensitivity TestsBiofilmsClarithromycinMacrophagesComputer SimulationHemolysisErythrocytesAmikacin

Stichwörter der Autor:innen

Mycobacterium abscessus subsp. massilienseadjuvant therapyantimicrobial resistancedeferoxamineiron chelation

Substanzen

DeferoxamineClarithromycinAnti-Bacterial AgentsAmikacinImmunomodulating Agents

Autor:innen und Institutionen

  • Postgraduate Program in Health Sciences, Federal University of Maranhão-UFMA, São Luís 65080-805, Brazil.
  • Postgraduate Program in Biosciences Applied to Health, CEUMA University-UNICEUMA, São Luís 65075-120, Brazil.
  • Medical School, CEUMA University-UNICEUMA, São Luís 65075-120, Brazil.
  • Postgraduate Program in Dentistry, CEUMA University-UNICEUMA, São Luís 65075-120, Brazil.

ORCID-Profile: Fabiane Barbosa Mendes, Pedro Lucas Brito Tromps Roxo, Flávia Danyelle Oliveira Nunes, José Lima Pereira-Filho, Carmem Duarte Lima Campos, Valério Monteiro-Neto, Rafael Cardoso Carvalho, Eduardo Martins de Sousa

Förderung

  • Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão
  • Universidade Ceuma
  • Foundation for the Support of Research and Scientific and Technological Development of Maranhão
  • CEUMA University

Zitieren

APA

Lira, R. L. S., Mendes, F. B., Roxo, P. L. B. T., Teixeira, J. T. A. M. M. M., de Azevedo, C. C. S., Vidigal, A. A., Gimenes, E. C. M., Dos Santos, R. S. S., Filho, R. L., Nascimento, C. E. C., Nunes, F. D. O., Marques, M. C. P., Pereira-Filho, J. L., Campos, C. D. L., Monteiro-Neto, V., Carvalho, R. C., & Sousa, E. M. (2026). Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity Against Mycobacterium abscessus: Integrated In Silico and In Vitro Evidence. International Journal of Molecular Sciences, 27(13), 5789. https://doi.org/10.3390/ijms27135789

Vancouver

Lira RLS, Mendes FB, Roxo PLBT, Teixeira JTAMMM, de Azevedo CCS, Vidigal AA, et al. Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity Against Mycobacterium abscessus: Integrated In Silico and In Vitro Evidence. International Journal of Molecular Sciences. 2026;27(13):5789. doi:10.3390/ijms27135789

BibTeX
@article{Lira2026,
  author = {Lira, Roseane Lustosa de Santana and Mendes, Fabiane Barbosa and Roxo, Pedro Lucas Brito Tromps and Teixeira, Joana Tenório Albuquerque Madruga Mesquita Meireles and de Azevedo, Caio César Santana and Vidigal, Arícia de Azevedo and Gimenes, Eleonôra Costa Monteiro and Dos Santos, Reidson Stanley Soares and Filho, Rivaldo Lira and Nascimento, Camila Evangelista Carnib and Nunes, Flávia Danyelle Oliveira and Marques, Mayane Cristina Pereira and Pereira-Filho, José Lima and Campos, Carmem Duarte Lima and Monteiro-Neto, Valério and Carvalho, Rafael Cardoso and Sousa, Eduardo Martins de},
  title = {Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity Against Mycobacterium abscessus: Integrated In Silico and In Vitro Evidence},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5789},
  doi = {10.3390/ijms27135789}
}
Kostenlos starten →